Beneficial effects of interleukin-6 in neonatal mouse models of group B streptococcal disease.
about
Induction and termination of inflammatory signaling in group B streptococcal sepsis.Role of interleukin-6 in mortality from and physiologic response to sepsisEndogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production.Intracellular and extracellular cytokine production by human mixed mononuclear cells in response to group B streptococci.Improved survival and antagonistic effect of sodium fusidate on tumor necrosis factor alpha in a neonatal mouse model of endotoxin shockEndotoxin-induced lethality in neonatal mice is counteracted by interleukin-10 (IL-10) and exacerbated by anti-IL-10Neutrophils Directly Recognize Group B Streptococci and Contribute to Interleukin-1β Production during Infection.Interleukin-18 is an essential element in host resistance to experimental group B streptococcal disease in neonates.Humanized mice, a new model to study the influence of drug treatment on neonatal sepsisNeonatal Group B Streptococcal Disease in Otherwise Healthy Infants: Failure of Specific Neonatal Immune ResponsesHuman monocyte receptors involved in tumor necrosis factor responses to group B streptococcal products.Interleukin-10 protects neonatal mice from lethal group B streptococcal infection.Role of gamma interferon in a neonatal mouse model of group B streptococcal disease.Porins of Pseudomonas aeruginosa induce release of tumor necrosis factor alpha and interleukin-6 by human leukocytes.Role of interleukin 12 in experimental neonatal sepsis caused by group B streptococci.Combination therapy with ampicillin and azithromycin improved outcomes in a mouse model of group B streptococcal sepsis.Group B Streptococci Induce Proinflammatory Responses via a Protein Kinase D1-Dependent Pathway.The ubiquitous interleukin-6: a time for reappraisal.Codevelopment of Microbiota and Innate Immunity and the Risk for Group B Streptococcal Disease.A mouse model reproducing the pathophysiology of neonatal group B streptococcal infection
P2860
Q33608933-6D88B052-86E3-4A38-B05D-253908D1DEB7Q33769122-0AAAB1E4-2007-4A74-8056-3CFBDA34FEC2Q33788220-E6377217-5DFA-442B-9B6F-1144712667A7Q34003088-7A3F4489-5F80-4985-92AB-CD0F7C3B46B2Q35125777-5CD8DDEA-1C0F-48A2-8C06-8371104ADD10Q35231052-37DF5524-7202-4C48-B66E-BAD9160A9D31Q36100363-42C0B339-DB05-458B-86FE-38F2A610FD8CQ36228875-F89766EC-721C-4AA2-AD37-42F2FA805F7FQ36826887-9FDF4C28-D0C7-4D33-BAF1-90200D2106E9Q37683149-239A1A6C-6FD5-460D-B2C5-A498858645A6Q39514295-9744F2BB-107D-4DDE-98E1-C1824C2DEB6BQ39825532-BB367C3D-C457-4D8C-9E1E-3B64DB65E425Q39825588-8D89BE7D-0B27-4B06-B0EA-73BDE03A0CF7Q39829680-9F78B0D5-332E-4482-8CD2-83E554463966Q39830920-CD5D1A5B-121E-481B-AA29-DDBA0B8BC64DQ40113070-C7FAE2F3-464F-4BED-93A3-44F254D1DD12Q40230584-89A8529E-5FFD-4F7B-A183-1D27146D0833Q42407082-CF191589-8082-4D56-A102-B2FABE1EB003Q46247272-15097929-CBB5-42FC-8420-A64087BE463EQ58797746-D7BFF5CD-2C34-405A-88A2-15D5C0A6FFFE
P2860
Beneficial effects of interleukin-6 in neonatal mouse models of group B streptococcal disease.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Beneficial effects of interleu ...... group B streptococcal disease.
@en
type
label
Beneficial effects of interleu ...... group B streptococcal disease.
@en
prefLabel
Beneficial effects of interleu ...... group B streptococcal disease.
@en
P2093
P2860
P1476
Beneficial effects of interleu ...... group B streptococcal disease
@en
P2093
F Tomasello
M Migliardo
P2860
P304
P407
P577
1994-11-01T00:00:00Z